Opinion: We Need to Advocate for Patients During the Chemotherapy Shortage
Congress needs to enact legislation that ensures chemotherapy shortages become a thing of the past.
Opinion: The Media May Have Oversold AOH1996, City of Hope's Pioneering Cancer Drug
AOH1996, a drug named in honor of Anna Olivia Healy, is being tested in a phase 1 trial. As nurses, we must help our patients understand that phase 1 trials represent very early research.
Opinion: Tumor-Treating Fields Hold Promise in Metastatic Non–Small Cell Lung Cancer
TTFields therapy, when given in addition to standard systemic therapy, improved overall survival in patients with metastatic non–small cell lung cancer.
Opinion: The Chemotherapy Shortage Is Hard to Wrap Your Head Around
What happens when there is a shortage of chemotherapy drugs? How will this affect patients?
Colorectal Cancer Screening: Education, Advocacy, and Action
It is essential to continue to develop and incorporate educational strategies to increase screening for colorectal cancer in our communities.
Developing a High-Risk Cancer Prevention and Wellness Program to Meet Community Needs
The program’s initiative aims to identify those at increased risk for cancer through assessment and testing and then formulate a personalized evidence-based cancer surveillance or screening plan.
4 Ways to Help Patients With Metastatic Lung Cancer Find Meaning in Their Experiences
Oncology nurses can help patients with metastatic lung cancer find meaning in their experiences and potentially help them cope more effectively with their diagnosis.
Opinion: The Epic Rover App Is An Easy Way to Elevate Oncology Nursing Practice
I have been using the Epic Rover app on a hospital-provided iPhone for the last few months. It has helped me give medication faster and more efficiently.
Opinion: New Technology Can Help Improve Patient Communication in the Oncology Setting
Interpretation devices may have a useful application in cancer care.
Opinion: The Iris App Could Be a “Game-Changer” for Patients With Cancer
Iris app aims to leverage accessible technology to deliver supportive care to all patients with cancer.
Complex Cancer Cases: Veno-Occlusive Disease in a Pediatric Patient Receiving Nontransplant-Associated Chemotherapy
Veno-occlusive disease or sinusoidal obstruction syndrome is commonly associated as a complication with transplant in pediatric patients but can also be seen with chemotherapy alone.
Opinion: Professional Development Plans Can Help Build Nursing Resilience
Debi Fischer, MSW, BSN, BA, LCSW, RN, reviews key takeaways from a poster presented at the 2023 Oncology Nursing Society Congress.
Opinion: Wilderness Therapy Offers Benefits to Patients With Cancer
Wilderness therapy is a nontraditional form of therapy that uses components of exposure to outdoor activity and mental health treatment.
Cancer Support Groups of Interest to RNs and Social Workers
Debi Fischer, MSW, BSN, BA, LCSW, RN, walks through some cancer support groups that may be of interest to oncology specialists.
Opinion: Innovative Strategies Improve Travel Nurse Orientation at Major Cancer Center
At the 48th Annual Oncology Nursing Society Congress, nurses shared how they improved travel nurse orientation at their institution.
Integrative Health Resources for the Oncology RN or Social Worker
There are many educational resources available for nurses who are interested in improving their spirituality and wellness.
Are You Speaking the Same Language When Discussing Biomarkers With Your Patients?
A Multidisciplinary Approach Improves a Patient’s Experience With Colon Cancer
Early coordination with multiple specialty teams can maximize outcomes and improve quality of life for patients with complex metastatic disease.
Opinion: Novel Data Collection Method May Provide New Insight on Cancer Recurrence
An initiative in Florida will monitor cancer recurrence at a state-level, setting the bar for recurrence data collection and research.
Opinion: Improving Hospice Care Is a Concern for Oncology RNs and Social Workers
Access to hospice and palliative care is lacking in many low- and middle-income countries.
Opinion: Drama Therapy Can Be a Therapeutic Tool for Helping Patients Cope With Cancer
Drama therapy may be a unique approach to help patients with cancer express themselves and improve their emotional well-being. It can also help health care professionals improve their communication skills.
Opinion: Exploring Available Narrative Medicine Courses as an Oncology RN and Social Worker
Narrative medicine is relevant to health care professions and can be used to enhance patient as well as the clinician’s experiences.
Opinion: Narrative Oncology Can Help RNs and Social Workers Better Relate to Our Work
Narrative oncology is the practice of funneling our experience in health care into stories that are emotional and humanistic.
Opinion: Clear Communication Is A Form Of Patient Advocacy
We can help our patients feel supported is by providing them with clear information about their treatment plan and what to expect. By doing so, we empower them to take control of their own health.
Donation Awareness For The Month of February
National Donor Day happens during the month of February and is a great time to encourage people in your life to give.
Opinion: As RNs We Must Strive to Help Improve Cancer Prevention
Nurses should educate patients not only about screening guidelines, but about important cancer risks to help improve cancer prevention.
Nursing Education Can Be a Lifelong Marathon. Are You Ready for the Race?
Nursing education should be viewed as a long-course endeavor rather than a sprint.
Considerations for Premenopausal Women With TNBC
Triple-negative breast cancer often occurs in women younger than 40.
Opinion: Nurses on Social Media Have A Responsibility to Be Professional
Being an oncology nurse means supporting the patient—even through social media engagement.
Oncology RNs and Social Workers Play Key Role in Cervical Cancer Awareness and Advocacy
January is cervical cancer awareness month. This fourth article in a series underscores the role of the nurse or social workers in patient advocacy.
Neoadjuvant Durvalumab Combination Misses Mark in EGFR+ NSCLC
Durvalumab Garners Similar OS, Albeit Varied PFS, Outcomes in EGFR+ and EGFR-Wildtype NSCLC Subgroups
Quizartinib Extends Overall Survival Across Multiple Subgroups in FLT3-ITD+ AML
Repotrectinib Showcases Early Intracranial Responses in Select ROS1+ NSCLC
2 Clarke Drive Cranbury, NJ 08512